NCT04261010View on ClinicalTrials.gov

TNF and IL23 Blocking Agents Gene Expression Ratios in the Psoriatic Arthritis Synovium_(TIGERS) Study

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

January 14, 2020

Primary Completion Date

September 12, 2023

Study Completion Date

September 12, 2023

Conditions
Psoriatic Arthritis
Interventions
PROCEDURE

Global/single cell gene expression profiles obtained from Synovial biopsies

Global/single cell gene expression profiles obtained from synovial biopsies before and after 24 weeks of treatment with the drug.

Trial Locations (2)

1200

Adrien NZEUSSEU TOUKAP, Brussels

Unknown

Dirk ELEWAUT, Ghent

Sponsors
All Listed Sponsors
collaborator

Janssen-Cilag International NV

INDUSTRY

collaborator

University Hospital, Ghent

OTHER

lead

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

OTHER